Literature DB >> 9686347

The human arginases and arginase deficiency.

R Iyer1, C P Jenkinson, J G Vockley, R M Kern, W W Grody, S Cederbaum.   

Abstract

Arginase is the final enzyme in the urea cycle. Its deficiency is the least frequently described disorder of this cycle. It results primarily in elevated blood arginine, and less frequently in either persistent or acute elevations in blood ammonia. This appears to be due to a second arginase locus, expressed primarily in the kidney, which can be recruited to compensate, in part, for the deficiency of liver arginase. The liver arginase gene structure permitted study of the molecular pathology of patients with the disorder and the results of these studies and the inferences about the protein structure are presented. The conserved regions among all arginases allowed the cloning of AII, the second arginase isoform. It has been localized to the mitochondrion and is thought to be involved in ornithine biosynthesis. It shares the major conserved protein sequences, and structural features of liver arginase gene are also conserved. When AI and AII from various species are compared, it appears that the two diverged some time prior to the evolution of amphibians. The evidence for the role of AII in nitric oxide and polyamine metabolism is presented and this appears consonant with the data on the tissue distribution.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9686347     DOI: 10.1023/a:1005313809037

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  38 in total

1.  Human type II arginase: sequence analysis and tissue-specific expression.

Authors:  S M Morris; D Bhamidipati; D Kepka-Lenhart
Journal:  Gene       Date:  1997-07-09       Impact factor: 3.688

2.  Chromosomal localization of the human arginase II gene and tissue distribution of its mRNA.

Authors:  T Gotoh; M Araki; M Mori
Journal:  Biochem Biophys Res Commun       Date:  1997-04-17       Impact factor: 3.575

3.  Arginase activity determination. A marker of large bowel mucosa proliferation.

Authors:  P Kocna; P Fric; M Zavoral; T Pelech
Journal:  Eur J Clin Chem Clin Biochem       Date:  1996-08

4.  Isolation of human liver arginase cDNA and demonstration of nonhomology between the two human arginase genes.

Authors:  G J Dizikes; W W Grody; R M Kern; S D Cederbaum
Journal:  Biochem Biophys Res Commun       Date:  1986-11-26       Impact factor: 3.575

5.  [Hyperargininemia wityh arginase deficiency. A new familial metabolic disease. I. Clinical studies].

Authors:  H G Terheggen; A Schwenk; A Lowenthal; M van Sande; J P Colombo
Journal:  Z Kinderheilkd       Date:  1970

6.  A PvuII RFLP for the human liver arginase (ARG1) gene.

Authors:  J R Kidd; G J Dizikes; W W Grody; S D Cederbaum; K K Kidd
Journal:  Nucleic Acids Res       Date:  1986-12-09       Impact factor: 16.971

7.  Biochemical properties of arginase in human adult and fetal tissues.

Authors:  E B Spector; S C Rice; S Moedjono; B Bernard; S D Cederbaum
Journal:  Biochem Med       Date:  1982-10

8.  The free amino acids of human spinal fluid determined by ion exchange chromatography.

Authors:  J C Dickinson; P B Hamilton
Journal:  J Neurochem       Date:  1966-11       Impact factor: 5.372

9.  Molecular basis of phenotypic variation in patients with argininemia.

Authors:  T Uchino; S E Snyderman; M Lambert; I A Qureshi; S K Shapira; C Sansaricq; L M Smit; C Jakobs; I Matsuda
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

10.  Human liver-type arginase gene: structure of the gene and analysis of the promoter region.

Authors:  M Takiguchi; Y Haraguchi; M Mori
Journal:  Nucleic Acids Res       Date:  1988-09-26       Impact factor: 16.971

View more
  50 in total

Review 1.  Arginase-1 deficiency.

Authors:  Yuan Yan Sin; Garrett Baron; Andreas Schulze; Colin D Funk
Journal:  J Mol Med (Berl)       Date:  2015-10-14       Impact factor: 4.599

2.  Hepatic arginase deficiency fosters dysmyelination during postnatal CNS development.

Authors:  Xiao-Bo Liu; Jillian R Haney; Gloria Cantero; Jenna R Lambert; Marcos Otero-Garcia; Brian Truong; Andrea Gropman; Inma Cobos; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  JCI Insight       Date:  2019-09-05

3.  Impact of substrate protonation and tautomerization states on interactions with the active site of arginase I.

Authors:  Shanthi Nagagarajan; Fengtian Xue; Alexander D MacKerell
Journal:  J Chem Inf Model       Date:  2013-01-31       Impact factor: 4.956

4.  Human hepatocyte transplantation corrects the inherited metabolic liver disorder arginase deficiency in mice.

Authors:  Stephanie A K Angarita; Brian Truong; Suhail Khoja; Matthew Nitzahn; Abha K Rajbhandari; Irina Zhuravka; Sergio Duarte; Michael G Lin; Alex K Lam; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  Mol Genet Metab       Date:  2018-04-21       Impact factor: 4.797

5.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

6.  Long-term dietary restriction up-regulates activity and expression of renal arginase II in aging mice.

Authors:  T Majaw; R Sharma
Journal:  J Biosci       Date:  2017-06       Impact factor: 1.826

7.  Amino acids in CSF and plasma in hyperammonaemic coma due to arginase1 deficiency.

Authors:  S Scholl-Bürgi; S Baumgartner Sigl; J Häberle; E Haberlandt; K Rostásy; C Ertl; U Eichinger-Öttl; P Heinz-Erian; D Karall
Journal:  J Inherit Metab Dis       Date:  2008-12-06       Impact factor: 4.982

8.  Arginine administration decreases cerebral cortex acetylcholinesterase and serum butyrylcholinesterase probably by oxidative stress induction.

Authors:  Angela T S Wyse; Francieli M Stefanello; Fábria Chiarani; Débora Delwing; Clóvis M D Wannmacher; Moacir Wajner
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

9.  Protective effect of antioxidants on cerebrum oxidative damage caused by arginine on pyruvate kinase activity.

Authors:  Débora Delwing; Daniela Delwing de Lima; Bianca Scolaro; Gabriela G Kuss; José G P Cruz; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2009-08-26       Impact factor: 3.584

10.  Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice.

Authors:  Sandra M Wells; Mary C Buford; Christopher T Migliaccio; Andrij Holian
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-14       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.